Litigation Details for Array BioPharma, Inc. v. Alembic Pharmaceuticals Limited (D. Del. 2022)
✉ Email this page to a colleague
Array BioPharma, Inc. v. Alembic Pharmaceuticals Limited (D. Del. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-09-28 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | Referred To | ||
Patents | 10,005,761; 9,562,016; 9,598,376; 9,850,229; 9,980,944 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Array BioPharma, Inc. v. Alembic Pharmaceuticals Limited
Details for Array BioPharma, Inc. v. Alembic Pharmaceuticals Limited (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-04-16 | 93 | Opinion - Memorandum Opinion | '"229 patent"), 10,005,761 (the "'761 patent"), 9,562,016 (the '"…761 patents as the "Huang Patents" and the ' 016, '376, and '944 patents as the…certain terms in United States Patent Nos. 9,3 14,464 (the "'464 patent"), 9,850,229 (the …"016 patent"), 9,598,376 (the '"376 patent"), and 9,980,944 (the "'…that inform patent law." Id. The ultimate question of the proper construction of a patent is a question | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |